Effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients with moderate to severe chronic kidney disease: Meta-analysis of randomized controlled trials using unadjusted data

Severe Chronic Kidney Disease

Cardiovascular events and all-cause mortality in patients with type 2 diabetes TREATED with DIPEPTIDYL PEPTIDASE-4 inhibitors: An EXTENSIVE meta-analysis of randomized controlled trials

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2021.06.002 ◽

2021 ◽

Author(s):

Edoardo Mannucci ◽

Besmir Nreu ◽

Chiara Montereggi ◽

Benedetta Ragghianti ◽

Marco Gallo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

All Cause Mortality

Effects of dipeptidyl peptidase-4 inhibitors on beta-cell function and insulin resistance in type 2 diabetes: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/srep44865 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 12

Author(s):

Xiafei Lyu ◽

Xiaolin Zhu ◽

Bin Zhao ◽

Liang Du ◽

Dawei Chen ◽

...

Keyword(s):

Insulin Resistance ◽

Type 2 Diabetes ◽

Beta Cell Function ◽

Cell Function ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials

PLoS ONE ◽

10.1371/journal.pone.0187537 ◽

2017 ◽

Vol 12 (12) ◽

pp. e0187537 ◽

Cited By ~ 19

Author(s):

Jun Yang ◽

Chao Huang ◽

Shanshan Wu ◽

Yang Xu ◽

Ting Cai ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Bone Fracture ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Direct head-to-head comparison of glycaemic durability of dipeptidyl peptidase-4 inhibitors and sulphonylureas in patients with type 2 diabetes mellitus: A meta-analysis of long-term randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.13147 ◽

2017 ◽

Vol 20 (4) ◽

pp. 1029-1033 ◽

Cited By ~ 12

Author(s):

Kang Chen ◽

Deying Kang ◽

Miao Yu ◽

Ruya Zhang ◽

Ye Zhang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Direct Head ◽

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s202024 ◽

2019 ◽

Vol Volume 12 ◽

pp. 1513-1526 ◽

Cited By ~ 4

Author(s):

Na Wang ◽

Tao Yang ◽

Jie Li ◽

Xianfeng Zhang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Head-to-Head Comparison of the Hypoglycemic Efficacy and Safety Between Dipeptidyl Peptidase-4 Inhibitors and α-Glucosidase Inhibitors in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Pharmacology ◽

10.3389/fphar.2019.00777 ◽

2019 ◽

Vol 10 ◽

Cited By ~ 2

Author(s):

Zhaoliang Li ◽

Liang Zhao ◽

Leilei Yu ◽

Jie Yang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Glucosidase Inhibitors ◽

Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1416346 ◽

2018 ◽

Vol 34 (6) ◽

pp. 1021-1027 ◽

Cited By ~ 3

Author(s):

Huan Huang ◽

Sharash Shetty ◽

Elise Bauer ◽

Kathleen Lang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Dipeptidyl Peptidase 4 ◽

Severe Chronic Kidney Disease ◽

Prescribing Information

Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.03.016 ◽

2016 ◽

Vol 212 ◽

pp. 203-205 ◽

Cited By ~ 6

Author(s):

Amartya Kundu ◽

Partha Sardar ◽

Sreeparna Ghosh ◽

Parth Patel ◽

Saurav Chatterjee ◽

...

Keyword(s):

Diabetes Mellitus ◽

Heart Failure ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials

Diabetes Care ◽

10.2337/dc18-1578 ◽

2019 ◽

Vol 42 (7) ◽

pp. e119-e121 ◽

Cited By ~ 4

Author(s):

Guangyao Li ◽

Matthew J. Crowley ◽

Huilin Tang ◽

Jeff Y. Yang ◽

Robert S. Sandler ◽

...

Keyword(s):

Type 2 Diabetes ◽

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Inflammatory Bowel

Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01380.x ◽

2011 ◽

Vol 13 (7) ◽

pp. 594-603 ◽

Cited By ~ 68

Author(s):

K. Esposito ◽

D. Cozzolino ◽

G. Bellastella ◽

M. I. Maiorino ◽

P. Chiodini ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Hba1c Target